Recurrent Urethral Cancer Withdrawn Phase 2 Trials for DB00997 (Doxorubicin)

Also known as: Urethral cancer recurrent / Urethra cancer recurrent

IndicationStatusPhase
DBCOND0028817 (Recurrent Urethral Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01639521Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerTreatment